company background image
INBS logo

Intelligent Bio Solutions NasdaqCM:INBS Stock Report

Last Price

US$1.48

Market Cap

US$6.5m

7D

3.5%

1Y

-61.0%

Updated

05 Jan, 2025

Data

Company Financials

Intelligent Bio Solutions Inc.

NasdaqCM:INBS Stock Report

Market Cap: US$6.5m

INBS Stock Overview

A medical technology company, developing rapid, non-invasive testing, and screening solutions. More details

INBS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Risk Analysis

Shareholders have been substantially diluted in the past year

Has less than 1 year of cash runway

Earnings have declined by 17.4% per year over past 5 years

Does not have a meaningful market cap ($6M)

+ 2 more risks

My Notes

Capture your thoughts, links and company narrative

Intelligent Bio Solutions Inc. Competitors

Sintx Technologies

NasdaqCM:SINT

US$5.0m

Predictive Oncology

NasdaqCM:POAI

US$8.0m

Kelyniam Global

OTCPK:KLYG

US$5.5m

Xylo Technologies

NasdaqCM:XYLO

US$2.9m

Price History & Performance

Summary of share price highs, lows and changes for Intelligent Bio Solutions
Historical stock prices
Current Share PriceUS$1.48
52 Week HighUS$11.70
52 Week LowUS$1.00
Beta4.69
1 Month Change-11.38%
3 Month Change-8.64%
1 Year Change-61.04%
3 Year Change-99.60%
5 Year Changen/a
Change since IPO-99.94%

Recent News & Updates

Recent updates

GBS acquires Intelligent Fingerprinting in all-stock deal

Oct 04

GBS GAAP EPS of -$0.57, revenue of $0.44M

Aug 31

GBS Inc.: Can Its Technology Come Through?

Aug 31

GBS Inc.: Pioneering Non-Invasive, Real-Time Diagnostic Testing

Aug 09

Is GBS (NASDAQ:GBS) In A Good Position To Invest In Growth?

Jul 29
Is GBS (NASDAQ:GBS) In A Good Position To Invest In Growth?

Shareholder Returns

INBSUS Medical EquipmentUS Market
7D3.5%-0.3%-0.2%
1Y-61.0%11.3%25.8%

Return vs Industry: INBS underperformed the US Medical Equipment industry which returned 11.3% over the past year.

Return vs Market: INBS underperformed the US Market which returned 25.8% over the past year.

Price Volatility

Is INBS's price volatile compared to industry and market?
INBS volatility
INBS Average Weekly Movement12.5%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.4%
10% most volatile stocks in US Market18.6%
10% least volatile stocks in US Market3.1%

Stable Share Price: INBS's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: INBS's weekly volatility has decreased from 32% to 13% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
201650Harry Simeonidisibs.inc

Intelligent Bio Solutions Inc., a medical technology company, developing rapid, non-invasive testing, and screening solutions. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse. It also operates biosensor platform for clinical chemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.

Intelligent Bio Solutions Inc. Fundamentals Summary

How do Intelligent Bio Solutions's earnings and revenue compare to its market cap?
INBS fundamental statistics
Market capUS$6.49m
Earnings (TTM)-US$10.42m
Revenue (TTM)US$3.19m

2.0x

P/S Ratio

-0.6x

P/E Ratio

Is INBS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
INBS income statement (TTM)
RevenueUS$3.19m
Cost of RevenueUS$1.65m
Gross ProfitUS$1.54m
Other ExpensesUS$11.96m
Earnings-US$10.42m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-2.37
Gross Margin48.31%
Net Profit Margin-326.77%
Debt/Equity Ratio8.4%

How did INBS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 02:13
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Intelligent Bio Solutions Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey CohenLadenburg Thalmann & Company
John VandermostenZacks Small-Cap Research